VEGFA-targeting Gene Therapy

· Shanghai BDgene Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VEGFA-targeting Gene Therapy, covering 2025-05-18 to 2025-05-18. Get the full timeline:

Most recent: Clinical Trial Update: VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases [EARLY_Phase 1]